Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
NGM Biopharmaceuticals, Inc
Stanford University
ADC Therapeutics S.A.
Pfizer
Rutgers, The State University of New Jersey
Revolution Medicines, Inc.
Ludwig Institute for Cancer Research
Pfizer
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Altor BioScience